

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.53543835 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.53543835 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.42328608 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.81727050 |
| 5 | synaptic vesicle maturation (GO:0016188) | 4.54196039 |
| 6 | glycerophospholipid catabolic process (GO:0046475) | 4.47908487 |
| 7 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 4.42777990 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.41198479 |
| 9 | cellular ketone body metabolic process (GO:0046950) | 4.40979407 |
| 10 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.32078350 |
| 11 | endocrine pancreas development (GO:0031018) | 4.31029908 |
| 12 | peptide hormone processing (GO:0016486) | 4.29080922 |
| 13 | insulin secretion (GO:0030073) | 4.26105971 |
| 14 | protein maturation by protein folding (GO:0022417) | 4.23913137 |
| 15 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.21671649 |
| 16 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.18822232 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 4.15445184 |
| 18 | epithelial cell fate commitment (GO:0072148) | 4.09320641 |
| 19 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.02724377 |
| 20 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.02039233 |
| 21 | inositol phosphate catabolic process (GO:0071545) | 3.93565023 |
| 22 | detection of calcium ion (GO:0005513) | 3.92865440 |
| 23 | ketone body metabolic process (GO:1902224) | 3.87972971 |
| 24 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.85973352 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.83085146 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 3.82770978 |
| 27 | cerebellar Purkinje cell layer development (GO:0021680) | 3.82629114 |
| 28 | locomotory exploration behavior (GO:0035641) | 3.77530360 |
| 29 | inositol phosphate dephosphorylation (GO:0046855) | 3.72113649 |
| 30 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.72113649 |
| 31 | glutamate secretion (GO:0014047) | 3.68961525 |
| 32 | protein retention in ER lumen (GO:0006621) | 3.68650857 |
| 33 | regulation of insulin secretion (GO:0050796) | 3.63319658 |
| 34 | positive regulation of gluconeogenesis (GO:0045722) | 3.61214012 |
| 35 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.60363013 |
| 36 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.53134000 |
| 37 | auditory receptor cell differentiation (GO:0042491) | 3.52110785 |
| 38 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.51051828 |
| 39 | positive regulation of insulin secretion (GO:0032024) | 3.50335459 |
| 40 | chemosensory behavior (GO:0007635) | 3.45453810 |
| 41 | protein targeting to Golgi (GO:0000042) | 3.41325156 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.41139789 |
| 43 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.40918282 |
| 44 | activation of protein kinase A activity (GO:0034199) | 3.38497675 |
| 45 | ER overload response (GO:0006983) | 3.37392913 |
| 46 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.36891052 |
| 47 | glandular epithelial cell differentiation (GO:0002067) | 3.36751824 |
| 48 | neurotransmitter secretion (GO:0007269) | 3.34158881 |
| 49 | COPII vesicle coating (GO:0048208) | 3.33957397 |
| 50 | vesicle coating (GO:0006901) | 3.30839657 |
| 51 | regulation of peptide hormone secretion (GO:0090276) | 3.30011275 |
| 52 | neuromuscular process controlling posture (GO:0050884) | 3.29220468 |
| 53 | regulation of peptide secretion (GO:0002791) | 3.27280457 |
| 54 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.25454427 |
| 55 | toxin metabolic process (GO:0009404) | 3.23833119 |
| 56 | peptide hormone secretion (GO:0030072) | 3.23805338 |
| 57 | nitric oxide biosynthetic process (GO:0006809) | 3.23800918 |
| 58 | respiratory chain complex IV assembly (GO:0008535) | 3.22359139 |
| 59 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.21112997 |
| 60 | positive regulation of exocytosis (GO:0045921) | 3.20369621 |
| 61 | positive regulation of nuclease activity (GO:0032075) | 3.19632440 |
| 62 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.17949829 |
| 63 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.17186589 |
| 64 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.17163348 |
| 65 | innervation (GO:0060384) | 3.16672602 |
| 66 | vocalization behavior (GO:0071625) | 3.16419470 |
| 67 | dendritic spine morphogenesis (GO:0060997) | 3.15651445 |
| 68 | peptide secretion (GO:0002790) | 3.14536158 |
| 69 | cellular response to glucagon stimulus (GO:0071377) | 3.14296918 |
| 70 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.11451982 |
| 71 | alanine transport (GO:0032328) | 3.10217543 |
| 72 | positive regulation of vesicle fusion (GO:0031340) | 3.09518252 |
| 73 | exploration behavior (GO:0035640) | 3.08846139 |
| 74 | regulation of vesicle fusion (GO:0031338) | 3.07883377 |
| 75 | establishment of protein localization to Golgi (GO:0072600) | 3.07368055 |
| 76 | positive regulation of neurotransmitter transport (GO:0051590) | 3.06653868 |
| 77 | suckling behavior (GO:0001967) | 3.05821889 |
| 78 | polyol catabolic process (GO:0046174) | 3.05618726 |
| 79 | regulation of hexokinase activity (GO:1903299) | 3.04972499 |
| 80 | regulation of glucokinase activity (GO:0033131) | 3.04972499 |
| 81 | membrane repolarization during action potential (GO:0086011) | 3.03674651 |
| 82 | neuron cell-cell adhesion (GO:0007158) | 3.02332895 |
| 83 | positive regulation of macroautophagy (GO:0016239) | 3.02321894 |
| 84 | cytochrome complex assembly (GO:0017004) | 3.00106058 |
| 85 | serotonin metabolic process (GO:0042428) | 2.99051234 |
| 86 | type B pancreatic cell development (GO:0003323) | 2.96778647 |
| 87 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.95899847 |
| 88 | inner ear receptor cell development (GO:0060119) | 2.95514125 |
| 89 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.94934454 |
| 90 | L-phenylalanine catabolic process (GO:0006559) | 2.94934454 |
| 91 | regulation of exocytosis (GO:0017157) | 2.94837142 |
| 92 | exocrine pancreas development (GO:0031017) | 2.94590353 |
| 93 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.94435679 |
| 94 | potassium ion export (GO:0071435) | 2.94389311 |
| 95 | nitric oxide mediated signal transduction (GO:0007263) | 2.94275337 |
| 96 | positive regulation of calcium ion import (GO:0090280) | 2.91661927 |
| 97 | response to pheromone (GO:0019236) | 2.89897589 |
| 98 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.89848784 |
| 99 | positive regulation of peptide secretion (GO:0002793) | 2.88933347 |
| 100 | positive regulation of peptide hormone secretion (GO:0090277) | 2.88495892 |
| 101 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.87982917 |
| 102 | regulation of extracellular matrix disassembly (GO:0010715) | 2.87778897 |
| 103 | regulation of hormone secretion (GO:0046883) | 2.86645395 |
| 104 | protein localization to Golgi apparatus (GO:0034067) | 2.86275542 |
| 105 | regulation of nuclease activity (GO:0032069) | 2.85158087 |
| 106 | signal release (GO:0023061) | 2.85117355 |
| 107 | regulation of beta-amyloid formation (GO:1902003) | 2.82814466 |
| 108 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.82707794 |
| 109 | negative regulation of catecholamine secretion (GO:0033604) | 2.82352708 |
| 110 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.81843091 |
| 111 | astrocyte differentiation (GO:0048708) | 2.81207325 |
| 112 | zinc ion homeostasis (GO:0055069) | 2.81192631 |
| 113 | glandular epithelial cell development (GO:0002068) | 2.81033936 |
| 114 | peptide transport (GO:0015833) | 2.80869163 |
| 115 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.80172199 |
| 116 | L-phenylalanine metabolic process (GO:0006558) | 2.80172199 |
| 117 | proline transport (GO:0015824) | 2.79934229 |
| 118 | cardiac left ventricle morphogenesis (GO:0003214) | 2.79623585 |
| 119 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.79411174 |
| 120 | regulation of autophagic vacuole assembly (GO:2000785) | 2.79387823 |
| 121 | catecholamine transport (GO:0051937) | 2.78085851 |
| 122 | inositol phosphate-mediated signaling (GO:0048016) | 2.77848422 |
| 123 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.77771778 |
| 124 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.77256964 |
| 125 | nodal signaling pathway (GO:0038092) | 2.76850218 |
| 126 | regulation of neurotransmitter uptake (GO:0051580) | 2.76718930 |
| 127 | regulation of glucocorticoid secretion (GO:2000849) | 2.76283078 |
| 128 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.73980147 |
| 129 | cellular potassium ion homeostasis (GO:0030007) | 2.73648285 |
| 130 | cell communication by electrical coupling (GO:0010644) | 2.73391399 |
| 131 | macroautophagy (GO:0016236) | 2.73066107 |
| 132 | neurotransmitter transport (GO:0006836) | 2.72179779 |
| 133 | vesicle transport along microtubule (GO:0047496) | 2.70705598 |
| 134 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.70235154 |
| 135 | negative regulation of hormone metabolic process (GO:0032351) | 2.69501537 |
| 136 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.69269355 |
| 137 | long-term synaptic potentiation (GO:0060291) | 2.68988882 |
| 138 | synaptic transmission, glutamatergic (GO:0035249) | 2.68323954 |
| 139 | regulation of ARF protein signal transduction (GO:0032012) | 2.68222060 |
| 140 | hormone secretion (GO:0046879) | 2.66119315 |
| 141 | brain morphogenesis (GO:0048854) | 2.65967569 |
| 142 | phenylpropanoid metabolic process (GO:0009698) | 2.63541352 |
| 143 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.63518749 |
| 144 | positive regulation of response to nutrient levels (GO:0032109) | 2.63352793 |
| 145 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.63352793 |
| 146 | cellular response to unfolded protein (GO:0034620) | 2.62989591 |
| 147 | signal peptide processing (GO:0006465) | 2.62613196 |
| 148 | regulation of peptide transport (GO:0090087) | 2.62523741 |
| 149 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.62503649 |
| 150 | regulation of neurotransmitter secretion (GO:0046928) | 2.62262450 |
| 151 | dopamine transport (GO:0015872) | 2.61624689 |
| 152 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.60261210 |
| 153 | protein localization to synapse (GO:0035418) | 2.60070567 |
| 154 | positive regulation of hormone secretion (GO:0046887) | 2.58011184 |
| 155 | regulation of vacuole organization (GO:0044088) | 2.57950933 |
| 156 | positive regulation of glycolytic process (GO:0045821) | 2.57697285 |
| 157 | cellular zinc ion homeostasis (GO:0006882) | 2.54983457 |
| 158 | positive regulation of meiosis (GO:0045836) | 2.54706024 |
| 159 | toxin transport (GO:1901998) | 2.53159390 |
| 160 | hormone transport (GO:0009914) | 2.51804022 |
| 161 | dopamine biosynthetic process (GO:0042416) | 2.51430756 |
| 162 | retinol metabolic process (GO:0042572) | 2.49082591 |
| 163 | regulation of protein glycosylation (GO:0060049) | 2.48811141 |
| 164 | regulation of execution phase of apoptosis (GO:1900117) | 2.48758538 |
| 165 | amide transport (GO:0042886) | 2.48738692 |
| 166 | calcium ion import (GO:0070509) | 2.48393943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.05672177 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.80624573 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.02282805 |
| 4 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.99872820 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66638178 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52797264 |
| 7 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.47215098 |
| 8 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41980716 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.37381631 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.32606646 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.22737883 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21329235 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21145205 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.21093014 |
| 15 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.16467978 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.16197937 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07263170 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05199962 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03091198 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02253563 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.01631806 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.01631806 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01034584 |
| 24 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.91492509 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89969178 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.89201247 |
| 27 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.88560505 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.86235645 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.84660328 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.74890840 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74208742 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73212732 |
| 33 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.72231189 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.70318888 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.70107249 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64930441 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.64766432 |
| 38 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59492769 |
| 39 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.56850990 |
| 40 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54504508 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52596887 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52587557 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52076099 |
| 44 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.50854499 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48230925 |
| 46 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47103554 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45354501 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41148302 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38551741 |
| 50 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.38068725 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37643489 |
| 52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37472820 |
| 53 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37212265 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34230815 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34141039 |
| 56 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.33135033 |
| 57 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32558281 |
| 58 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.29805220 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29302056 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29069729 |
| 61 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.27812095 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27163956 |
| 63 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25904659 |
| 64 | AR_19668381_ChIP-Seq_PC3_Human | 1.25699957 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25403056 |
| 66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22375417 |
| 67 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.22154523 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22013031 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21473968 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20315732 |
| 71 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.20244230 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19412647 |
| 73 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18139335 |
| 74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16854722 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16854722 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16501591 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16251843 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15874496 |
| 79 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15719684 |
| 80 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15714813 |
| 81 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15026164 |
| 82 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14911867 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14426568 |
| 84 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14184264 |
| 85 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.13051252 |
| 86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12277908 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12117208 |
| 88 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.11974530 |
| 89 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11875077 |
| 90 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10566903 |
| 91 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10048434 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09362666 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09306928 |
| 94 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09197584 |
| 95 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09197584 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09004643 |
| 97 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08660536 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07831005 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07400163 |
| 100 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07375051 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06956906 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05556780 |
| 103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04632667 |
| 104 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04440068 |
| 105 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.04052195 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02596553 |
| 107 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.02319998 |
| 108 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02149619 |
| 109 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02068981 |
| 110 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02024186 |
| 111 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02024186 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00975602 |
| 113 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.00823251 |
| 114 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00808456 |
| 115 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00259420 |
| 116 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00065729 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98955306 |
| 118 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98319870 |
| 119 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98295914 |
| 120 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97954127 |
| 121 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97597166 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97596505 |
| 123 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97400139 |
| 124 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97304192 |
| 125 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97254098 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96620982 |
| 127 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.96567867 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96534235 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96412783 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94754334 |
| 131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94233637 |
| 132 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94145963 |
| 133 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93535996 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93125015 |
| 135 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.93121913 |
| 136 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92723784 |
| 137 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89256369 |
| 138 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88278368 |
| 139 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88168114 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87330347 |
| 141 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86490588 |
| 142 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.85634863 |
| 143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85127099 |
| 144 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84863938 |
| 145 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83709266 |
| 146 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.81731188 |
| 147 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80935708 |
| 148 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.80254533 |
| 149 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.79050123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 3.83878511 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.59160928 |
| 3 | MP0003283_abnormal_digestive_organ | 3.45325497 |
| 4 | * MP0002909_abnormal_adrenal_gland | 3.29220042 |
| 5 | MP0000013_abnormal_adipose_tissue | 3.26351523 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 3.09868106 |
| 7 | MP0004043_abnormal_pH_regulation | 3.06229842 |
| 8 | MP0004270_analgesia | 3.03709112 |
| 9 | MP0010386_abnormal_urinary_bladder | 2.80268256 |
| 10 | MP0003122_maternal_imprinting | 2.74329504 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.73372525 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.61996586 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.56530339 |
| 14 | * MP0002693_abnormal_pancreas_physiology | 2.55282146 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 2.47240982 |
| 16 | MP0001944_abnormal_pancreas_morphology | 2.44938129 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.39052173 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.31271109 |
| 19 | MP0005379_endocrine/exocrine_gland_phen | 2.27071581 |
| 20 | MP0005646_abnormal_pituitary_gland | 2.16296904 |
| 21 | MP0003880_abnormal_central_pattern | 2.13687236 |
| 22 | MP0002063_abnormal_learning/memory/cond | 2.08606385 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 2.03812646 |
| 24 | MP0003787_abnormal_imprinting | 2.03194875 |
| 25 | MP0009745_abnormal_behavioral_response | 1.99518861 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 1.99408353 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 1.96996252 |
| 28 | MP0002064_seizures | 1.93824015 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.93255534 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.87213657 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.87191622 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.86122583 |
| 33 | MP0002272_abnormal_nervous_system | 1.83704428 |
| 34 | MP0003195_calcinosis | 1.82844767 |
| 35 | MP0009046_muscle_twitch | 1.82085205 |
| 36 | MP0002254_reproductive_system_inflammat | 1.76688786 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.66053392 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.64083757 |
| 39 | * MP0002078_abnormal_glucose_homeostasis | 1.61412952 |
| 40 | MP0001756_abnormal_urination | 1.60114266 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.59402386 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.58157018 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.53875118 |
| 44 | MP0005332_abnormal_amino_acid | 1.53632314 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.48375244 |
| 46 | MP0003879_abnormal_hair_cell | 1.46130022 |
| 47 | MP0001970_abnormal_pain_threshold | 1.42209401 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.39258414 |
| 49 | MP0008569_lethality_at_weaning | 1.36996988 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.35281218 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.34973814 |
| 52 | MP0002234_abnormal_pharynx_morphology | 1.34293487 |
| 53 | MP0001765_abnormal_ion_homeostasis | 1.33934648 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 1.33184032 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.32269736 |
| 56 | MP0001486_abnormal_startle_reflex | 1.30912707 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.30679424 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.29234196 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.28289544 |
| 60 | MP0002184_abnormal_innervation | 1.27312324 |
| 61 | MP0003123_paternal_imprinting | 1.24987874 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.24648251 |
| 63 | MP0000631_abnormal_neuroendocrine_gland | 1.24505378 |
| 64 | MP0005535_abnormal_body_temperature | 1.24367219 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 1.23949478 |
| 66 | MP0001905_abnormal_dopamine_level | 1.23546917 |
| 67 | MP0005365_abnormal_bile_salt | 1.23254497 |
| 68 | MP0000955_abnormal_spinal_cord | 1.21147183 |
| 69 | * MP0003953_abnormal_hormone_level | 1.20437957 |
| 70 | MP0004811_abnormal_neuron_physiology | 1.20145562 |
| 71 | MP0002822_catalepsy | 1.17999368 |
| 72 | MP0004858_abnormal_nervous_system | 1.16248823 |
| 73 | MP0005386_behavior/neurological_phenoty | 1.16208269 |
| 74 | MP0004924_abnormal_behavior | 1.16208269 |
| 75 | MP0002735_abnormal_chemical_nociception | 1.15372132 |
| 76 | MP0001986_abnormal_taste_sensitivity | 1.14684251 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 1.11896080 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 1.09832867 |
| 79 | MP0003011_delayed_dark_adaptation | 1.07657227 |
| 80 | MP0004133_heterotaxia | 1.07371177 |
| 81 | MP0003329_amyloid_beta_deposits | 1.05681837 |
| 82 | MP0003633_abnormal_nervous_system | 0.99755667 |
| 83 | MP0001984_abnormal_olfaction | 0.98868009 |
| 84 | MP0002069_abnormal_eating/drinking_beha | 0.98179159 |
| 85 | MP0002882_abnormal_neuron_morphology | 0.96466150 |
| 86 | MP0002229_neurodegeneration | 0.96314894 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 0.95592994 |
| 88 | MP0002090_abnormal_vision | 0.94883090 |
| 89 | MP0000462_abnormal_digestive_system | 0.94523943 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 0.94521659 |
| 91 | MP0005253_abnormal_eye_physiology | 0.94426853 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.93832487 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.92988058 |
| 94 | MP0003045_fibrosis | 0.92649101 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.91892915 |
| 96 | MP0004085_abnormal_heartbeat | 0.90439222 |
| 97 | MP0003121_genomic_imprinting | 0.89341063 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.87989001 |
| 99 | MP0008872_abnormal_physiological_respon | 0.87840532 |
| 100 | MP0002736_abnormal_nociception_after | 0.86930140 |
| 101 | MP0002938_white_spotting | 0.86643103 |
| 102 | MP0005174_abnormal_tail_pigmentation | 0.86317418 |
| 103 | MP0004233_abnormal_muscle_weight | 0.85103872 |
| 104 | MP0002928_abnormal_bile_duct | 0.82121587 |
| 105 | MP0001664_abnormal_digestion | 0.82005174 |
| 106 | MP0004885_abnormal_endolymph | 0.81958346 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.81159750 |
| 108 | MP0004142_abnormal_muscle_tone | 0.79963744 |
| 109 | MP0005187_abnormal_penis_morphology | 0.78397398 |
| 110 | MP0002163_abnormal_gland_morphology | 0.78064300 |
| 111 | MP0003868_abnormal_feces_composition | 0.78052925 |
| 112 | MP0005448_abnormal_energy_balance | 0.77798482 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.77631097 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.77196536 |
| 115 | * MP0000639_abnormal_adrenal_gland | 0.77181251 |
| 116 | MP0004147_increased_porphyrin_level | 0.76571760 |
| 117 | MP0003959_abnormal_lean_body | 0.75768794 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.75017251 |
| 119 | MP0003866_abnormal_defecation | 0.74453297 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.74123311 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.73577111 |
| 122 | MP0002653_abnormal_ependyma_morphology | 0.73033569 |
| 123 | MP0000427_abnormal_hair_cycle | 0.72348588 |
| 124 | MP0005452_abnormal_adipose_tissue | 0.71709915 |
| 125 | MP0000778_abnormal_nervous_system | 0.71441025 |
| 126 | MP0003119_abnormal_digestive_system | 0.69784898 |
| 127 | MP0002751_abnormal_autonomic_nervous | 0.67703061 |
| 128 | MP0000569_abnormal_digit_pigmentation | 0.67164772 |
| 129 | MP0003631_nervous_system_phenotype | 0.67028269 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.65254145 |
| 131 | MP0000372_irregular_coat_pigmentation | 0.63920296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.52297186 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.60191663 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.88334062 |
| 4 | Symptomatic seizures (HP:0011145) | 4.50256864 |
| 5 | Visual hallucinations (HP:0002367) | 4.50087836 |
| 6 | Agitation (HP:0000713) | 4.41143578 |
| 7 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.26313541 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.23320417 |
| 9 | Congenital malformation of the right heart (HP:0011723) | 4.01703666 |
| 10 | Double outlet right ventricle (HP:0001719) | 4.01703666 |
| 11 | Decreased circulating renin level (HP:0003351) | 3.89660989 |
| 12 | Focal motor seizures (HP:0011153) | 3.84034294 |
| 13 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.69578684 |
| 14 | Intestinal atresia (HP:0011100) | 3.68895953 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.66132429 |
| 16 | Hyperglycemia (HP:0003074) | 3.64159156 |
| 17 | Pheochromocytoma (HP:0002666) | 3.52601699 |
| 18 | Ketoacidosis (HP:0001993) | 3.52111286 |
| 19 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.51655167 |
| 20 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.51655167 |
| 21 | Hypercortisolism (HP:0001578) | 3.34174286 |
| 22 | Abnormality of vitamin B metabolism (HP:0004340) | 3.32819752 |
| 23 | Atonic seizures (HP:0010819) | 3.31357989 |
| 24 | Papilledema (HP:0001085) | 3.19422140 |
| 25 | Epileptiform EEG discharges (HP:0011182) | 3.13575488 |
| 26 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.13225317 |
| 27 | EEG with generalized epileptiform discharges (HP:0011198) | 3.12293874 |
| 28 | Neuroendocrine neoplasm (HP:0100634) | 3.09812332 |
| 29 | Menstrual irregularities (HP:0000858) | 3.07718400 |
| 30 | Epileptic encephalopathy (HP:0200134) | 3.06461546 |
| 31 | Large for gestational age (HP:0001520) | 3.05943206 |
| 32 | Absence seizures (HP:0002121) | 3.04188358 |
| 33 | Hypsarrhythmia (HP:0002521) | 3.00433952 |
| 34 | Increased CSF protein (HP:0002922) | 2.98341754 |
| 35 | Focal seizures (HP:0007359) | 2.93633848 |
| 36 | Late onset (HP:0003584) | 2.88653483 |
| 37 | Ketosis (HP:0001946) | 2.88136907 |
| 38 | Abnormality of vitamin metabolism (HP:0100508) | 2.83246846 |
| 39 | Methylmalonic acidemia (HP:0002912) | 2.79038065 |
| 40 | Hyperparathyroidism (HP:0000843) | 2.75185414 |
| 41 | Abnormal pancreas size (HP:0012094) | 2.73993891 |
| 42 | Retinal atrophy (HP:0001105) | 2.71533474 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69755341 |
| 44 | Mucopolysacchariduria (HP:0008155) | 2.69755341 |
| 45 | Depression (HP:0000716) | 2.68932874 |
| 46 | Anxiety (HP:0000739) | 2.66631666 |
| 47 | Abnormality of renin-angiotensin system (HP:0000847) | 2.62209459 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.60300421 |
| 49 | Dialeptic seizures (HP:0011146) | 2.59892901 |
| 50 | Generalized tonic-clonic seizures (HP:0002069) | 2.56304871 |
| 51 | Myokymia (HP:0002411) | 2.53712911 |
| 52 | Action tremor (HP:0002345) | 2.52150636 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51772540 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51772540 |
| 55 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51772540 |
| 56 | Restlessness (HP:0000711) | 2.50001413 |
| 57 | Macroorchidism (HP:0000053) | 2.48788458 |
| 58 | Hypokalemia (HP:0002900) | 2.47431802 |
| 59 | Adrenal overactivity (HP:0002717) | 2.47161718 |
| 60 | Progressive cerebellar ataxia (HP:0002073) | 2.46805680 |
| 61 | Progressive neurologic deterioration (HP:0002344) | 2.45246883 |
| 62 | Medial flaring of the eyebrow (HP:0010747) | 2.42999770 |
| 63 | Muscular hypotonia of the trunk (HP:0008936) | 2.39980227 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.37992130 |
| 65 | Febrile seizures (HP:0002373) | 2.37721641 |
| 66 | Progressive macrocephaly (HP:0004481) | 2.36296985 |
| 67 | Failure to thrive in infancy (HP:0001531) | 2.34425498 |
| 68 | Hypothermia (HP:0002045) | 2.32659970 |
| 69 | Limb dystonia (HP:0002451) | 2.32463739 |
| 70 | Truncal ataxia (HP:0002078) | 2.32415076 |
| 71 | Postural tremor (HP:0002174) | 2.31666479 |
| 72 | Hypokinesia (HP:0002375) | 2.29655084 |
| 73 | Increased circulating renin level (HP:0000848) | 2.28546435 |
| 74 | Polyphagia (HP:0002591) | 2.26639120 |
| 75 | Methylmalonic aciduria (HP:0012120) | 2.23626411 |
| 76 | Hypomagnesemia (HP:0002917) | 2.21347840 |
| 77 | Proximal tubulopathy (HP:0000114) | 2.21093086 |
| 78 | Hyperkalemia (HP:0002153) | 2.18560778 |
| 79 | Polydipsia (HP:0001959) | 2.18021989 |
| 80 | Abnormal drinking behavior (HP:0030082) | 2.18021989 |
| 81 | Gaze-evoked nystagmus (HP:0000640) | 2.16591702 |
| 82 | Poor suck (HP:0002033) | 2.15243026 |
| 83 | Abnormality of potassium homeostasis (HP:0011042) | 2.14047579 |
| 84 | Congenital sensorineural hearing impairment (HP:0008527) | 2.13188140 |
| 85 | Testicular neoplasm (HP:0010788) | 2.12669058 |
| 86 | Supranuclear gaze palsy (HP:0000605) | 2.12621601 |
| 87 | Growth hormone excess (HP:0000845) | 2.11982150 |
| 88 | Hypoalbuminemia (HP:0003073) | 2.11088143 |
| 89 | Abnormal albumin level (HP:0012116) | 2.11088143 |
| 90 | Glycosuria (HP:0003076) | 2.09104922 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 2.09104922 |
| 92 | Ventricular fibrillation (HP:0001663) | 2.08333725 |
| 93 | Orthostatic hypotension (HP:0001278) | 2.04137844 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 2.03839642 |
| 95 | Hyperphosphatemia (HP:0002905) | 2.01707501 |
| 96 | Unilateral renal agenesis (HP:0000122) | 2.01007786 |
| 97 | Abnormality of the renal cortex (HP:0011035) | 2.00425720 |
| 98 | Diminished movement (HP:0002374) | 1.99818470 |
| 99 | Dysautonomia (HP:0002459) | 1.99373324 |
| 100 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.98916079 |
| 101 | Cortical visual impairment (HP:0100704) | 1.97296553 |
| 102 | Neoplasm of the heart (HP:0100544) | 1.96329433 |
| 103 | Insulin resistance (HP:0000855) | 1.95318741 |
| 104 | Intention tremor (HP:0002080) | 1.93992516 |
| 105 | Attenuation of retinal blood vessels (HP:0007843) | 1.93824752 |
| 106 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93124841 |
| 107 | Vascular calcification (HP:0004934) | 1.91480823 |
| 108 | Hyperthyroidism (HP:0000836) | 1.91377184 |
| 109 | Pancreatic fibrosis (HP:0100732) | 1.89756388 |
| 110 | Gait imbalance (HP:0002141) | 1.89344373 |
| 111 | Abnormal sex determination (HP:0012244) | 1.88618580 |
| 112 | Sex reversal (HP:0012245) | 1.88618580 |
| 113 | Mesangial abnormality (HP:0001966) | 1.88172719 |
| 114 | Drooling (HP:0002307) | 1.86831614 |
| 115 | Excessive salivation (HP:0003781) | 1.86831614 |
| 116 | Congenital glaucoma (HP:0001087) | 1.86087656 |
| 117 | Amblyopia (HP:0000646) | 1.83358073 |
| 118 | Hypotension (HP:0002615) | 1.83151192 |
| 119 | Abnormal eating behavior (HP:0100738) | 1.82956484 |
| 120 | Poor eye contact (HP:0000817) | 1.82937570 |
| 121 | Nephronophthisis (HP:0000090) | 1.82856941 |
| 122 | Prominent metopic ridge (HP:0005487) | 1.82747576 |
| 123 | Hyperventilation (HP:0002883) | 1.80956655 |
| 124 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.80598261 |
| 125 | Congenital primary aphakia (HP:0007707) | 1.79754483 |
| 126 | Ankle clonus (HP:0011448) | 1.79037437 |
| 127 | Hyperactive renin-angiotensin system (HP:0000841) | 1.77954881 |
| 128 | Mitochondrial inheritance (HP:0001427) | 1.76788044 |
| 129 | Type II lissencephaly (HP:0007260) | 1.76497782 |
| 130 | Psychosis (HP:0000709) | 1.76272432 |
| 131 | Pancreatic cysts (HP:0001737) | 1.75498315 |
| 132 | Urethral obstruction (HP:0000796) | 1.75395436 |
| 133 | Abnormal EKG (HP:0003115) | 1.75199779 |
| 134 | Hamartoma of the eye (HP:0010568) | 1.74870556 |
| 135 | Hemiparesis (HP:0001269) | 1.74507259 |
| 136 | Resting tremor (HP:0002322) | 1.74415368 |
| 137 | Tongue fasciculations (HP:0001308) | 1.74311899 |
| 138 | Enlarged penis (HP:0000040) | 1.74252756 |
| 139 | Conjunctival hamartoma (HP:0100780) | 1.72660262 |
| 140 | Genetic anticipation (HP:0003743) | 1.72633627 |
| 141 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.72173346 |
| 142 | Episodic fever (HP:0001954) | 1.71935972 |
| 143 | Aqueductal stenosis (HP:0002410) | 1.71732158 |
| 144 | Syncope (HP:0001279) | 1.70820845 |
| 145 | Generalized hyperpigmentation (HP:0007440) | 1.70126467 |
| 146 | Abnormal social behavior (HP:0012433) | 1.69705817 |
| 147 | Impaired social interactions (HP:0000735) | 1.69705817 |
| 148 | Prolonged QT interval (HP:0001657) | 1.68675190 |
| 149 | Dysdiadochokinesis (HP:0002075) | 1.68192619 |
| 150 | Osteomalacia (HP:0002749) | 1.67770050 |
| 151 | Hypoventilation (HP:0002791) | 1.67371524 |
| 152 | Type II diabetes mellitus (HP:0005978) | 1.67303076 |
| 153 | Limb hypertonia (HP:0002509) | 1.67031897 |
| 154 | Abnormality of the fovea (HP:0000493) | 1.66950807 |
| 155 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.66855228 |
| 156 | Villous atrophy (HP:0011473) | 1.66855228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.35056341 |
| 2 | NTRK3 | 4.22360327 |
| 3 | TAOK3 | 3.26555592 |
| 4 | PASK | 3.18695026 |
| 5 | PRKD3 | 3.12990615 |
| 6 | PHKG1 | 3.09832218 |
| 7 | PHKG2 | 3.09832218 |
| 8 | FGFR2 | 2.82820535 |
| 9 | MAPK15 | 2.71777475 |
| 10 | MAP3K2 | 2.58462002 |
| 11 | UHMK1 | 2.51289490 |
| 12 | PINK1 | 2.45715392 |
| 13 | MAP3K9 | 2.40721576 |
| 14 | MAP4K2 | 2.40584190 |
| 15 | NTRK1 | 2.31968368 |
| 16 | HIPK2 | 2.31406072 |
| 17 | CAMKK2 | 2.28842800 |
| 18 | GRK1 | 2.27395828 |
| 19 | MST4 | 2.18395400 |
| 20 | MAP3K4 | 2.18282165 |
| 21 | MAP2K6 | 2.12860617 |
| 22 | FRK | 2.02759809 |
| 23 | WNK3 | 2.00739203 |
| 24 | ADRBK2 | 1.86319838 |
| 25 | SCYL2 | 1.78214522 |
| 26 | TRPM7 | 1.71602740 |
| 27 | AKT3 | 1.71354339 |
| 28 | CSNK1G1 | 1.70718303 |
| 29 | CASK | 1.64827119 |
| 30 | MAP2K7 | 1.62825959 |
| 31 | DAPK2 | 1.60894965 |
| 32 | CAMKK1 | 1.57987899 |
| 33 | EPHA4 | 1.57919725 |
| 34 | FGFR3 | 1.56935030 |
| 35 | MAP3K1 | 1.55168338 |
| 36 | MINK1 | 1.51167201 |
| 37 | PAK6 | 1.48929658 |
| 38 | WNK4 | 1.45306438 |
| 39 | MARK1 | 1.43537190 |
| 40 | CSNK1G3 | 1.41672388 |
| 41 | KSR2 | 1.36831149 |
| 42 | CDC42BPA | 1.32812501 |
| 43 | PRKCH | 1.30883658 |
| 44 | NLK | 1.24885888 |
| 45 | MAP2K4 | 1.18269463 |
| 46 | CDK5 | 1.16740176 |
| 47 | PAK3 | 1.15039103 |
| 48 | PNCK | 1.13079477 |
| 49 | GRK5 | 1.11300309 |
| 50 | RET | 1.10310938 |
| 51 | STK38L | 1.09099069 |
| 52 | PDGFRA | 1.03721886 |
| 53 | PTK2 | 1.02163999 |
| 54 | NTRK2 | 1.01436565 |
| 55 | DAPK1 | 1.01308190 |
| 56 | STK3 | 1.00060139 |
| 57 | ACVR1B | 0.98770098 |
| 58 | ERBB3 | 0.96049006 |
| 59 | PRKCG | 0.92616154 |
| 60 | ERN1 | 0.91265726 |
| 61 | FLT3 | 0.90620226 |
| 62 | WNK1 | 0.90097601 |
| 63 | STK24 | 0.88528905 |
| 64 | LMTK2 | 0.85700187 |
| 65 | CAMK2A | 0.84493740 |
| 66 | TAOK1 | 0.84403634 |
| 67 | MAP3K12 | 0.83736437 |
| 68 | SGK223 | 0.81706787 |
| 69 | SGK494 | 0.81706787 |
| 70 | BMPR1B | 0.79505186 |
| 71 | CAMK2B | 0.79349348 |
| 72 | RIPK1 | 0.78321822 |
| 73 | OXSR1 | 0.78228622 |
| 74 | FER | 0.77477696 |
| 75 | CAMK2D | 0.75779919 |
| 76 | TNK2 | 0.74444668 |
| 77 | PTK2B | 0.73498618 |
| 78 | ARAF | 0.73356582 |
| 79 | CDK19 | 0.73287348 |
| 80 | PRKCE | 0.72532237 |
| 81 | PLK2 | 0.72254670 |
| 82 | TNIK | 0.71678993 |
| 83 | PRKCI | 0.71617710 |
| 84 | CAMK1G | 0.71434722 |
| 85 | MKNK2 | 0.70476635 |
| 86 | CAMK1 | 0.69910836 |
| 87 | KSR1 | 0.69391931 |
| 88 | SGK2 | 0.68450712 |
| 89 | RIPK4 | 0.67888366 |
| 90 | BRAF | 0.65806537 |
| 91 | STK38 | 0.65138871 |
| 92 | YES1 | 0.64771040 |
| 93 | ALK | 0.63872924 |
| 94 | BRSK1 | 0.63338149 |
| 95 | CCNB1 | 0.62897348 |
| 96 | MAPK13 | 0.62307461 |
| 97 | STK39 | 0.61718304 |
| 98 | CSNK1A1L | 0.61215611 |
| 99 | PRKD2 | 0.60868395 |
| 100 | PRKG2 | 0.59383499 |
| 101 | MARK2 | 0.57135067 |
| 102 | SGK3 | 0.57111407 |
| 103 | DYRK1A | 0.56264552 |
| 104 | LIMK1 | 0.56167281 |
| 105 | PRKG1 | 0.53550100 |
| 106 | SGK1 | 0.52313508 |
| 107 | BMPR2 | 0.50781425 |
| 108 | STK11 | 0.50024179 |
| 109 | IRAK1 | 0.47683441 |
| 110 | PRKAA2 | 0.47479560 |
| 111 | BCR | 0.47181330 |
| 112 | DYRK1B | 0.46729984 |
| 113 | RPS6KA3 | 0.46212978 |
| 114 | PDPK1 | 0.45802948 |
| 115 | CSNK1D | 0.45689594 |
| 116 | RPS6KA2 | 0.45636671 |
| 117 | PDK1 | 0.45238143 |
| 118 | CSNK1A1 | 0.44726500 |
| 119 | GSK3A | 0.44559274 |
| 120 | EPHA3 | 0.44231234 |
| 121 | PRKACG | 0.42140792 |
| 122 | PRKACA | 0.41732957 |
| 123 | PRKAA1 | 0.41123253 |
| 124 | CDK14 | 0.40871829 |
| 125 | PRKCZ | 0.39297793 |
| 126 | MAP2K1 | 0.38489062 |
| 127 | PIK3CG | 0.38111676 |
| 128 | MAPK10 | 0.38043779 |
| 129 | PRKCA | 0.37971530 |
| 130 | CSNK1E | 0.37778971 |
| 131 | CSNK1G2 | 0.37225838 |
| 132 | PTK6 | 0.37134868 |
| 133 | IRAK2 | 0.37066138 |
| 134 | TRIB3 | 0.36773070 |
| 135 | CDK18 | 0.36604370 |
| 136 | ADRBK1 | 0.36438307 |
| 137 | FES | 0.35429009 |
| 138 | ZAK | 0.35226679 |
| 139 | CDK15 | 0.34963685 |
| 140 | CAMK4 | 0.33629008 |
| 141 | PRKACB | 0.33471977 |
| 142 | CAMK2G | 0.32347059 |
| 143 | NEK6 | 0.31779128 |
| 144 | PRKCB | 0.31578277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.49475169 |
| 2 | Insulin secretion_Homo sapiens_hsa04911 | 3.40443855 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.71095894 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.50135984 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.41247510 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.39290294 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.33368370 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.24671262 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.21846377 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20339901 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.14088742 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13968713 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.12844776 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 2.08672370 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.08605780 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 2.05362393 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94401410 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.92357198 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.91820744 |
| 20 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.85759194 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.84397640 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.84140219 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80360306 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.79370228 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.78657757 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73670291 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.71658136 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63950989 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63162973 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60411096 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.59590470 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.57577534 |
| 33 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.52343120 |
| 34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.50940770 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46897681 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.45063018 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35031553 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.34602149 |
| 39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.33185763 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30851501 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.30694748 |
| 42 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.27896284 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23560761 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20609066 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16253060 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14165657 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08520815 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06387809 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05680475 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04376913 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03629561 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03435130 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00628768 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00487829 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97678041 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97403059 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97184163 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.95923749 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94409539 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.94390113 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.94038592 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93681472 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92123074 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92088431 |
| 65 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89019448 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87442843 |
| 67 | Gap junction_Homo sapiens_hsa04540 | 0.86598076 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.78450876 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77242074 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76004425 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75954004 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75256416 |
| 73 | Melanogenesis_Homo sapiens_hsa04916 | 0.69846668 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69022662 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.68608173 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66893189 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66385271 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66369183 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.65712139 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.65194553 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65061897 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65021590 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64739892 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64641621 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64522394 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63985055 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63037479 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62106835 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59810996 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58635927 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.58193118 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.56544479 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55069196 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54434919 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53256514 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52890641 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52585091 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52572204 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52466105 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52286984 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51566796 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51436548 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51411277 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50687515 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50681017 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50287742 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49768881 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49130354 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48157680 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48124357 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46955498 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45288198 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44190987 |
| 114 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43215359 |
| 115 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41456020 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41123815 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39220275 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39089760 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38331508 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36901463 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36874491 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.36745027 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35434044 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35416106 |
| 125 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31510257 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26982965 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26973872 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.25088724 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24959378 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.24898397 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23806048 |
| 132 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.22575552 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.22107650 |
| 134 | Endometrial cancer_Homo sapiens_hsa05213 | 0.20322144 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17230887 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.17151300 |

